Back
Vanguard Communication Services ETF Vs. Halozyme Therapeutics Industry Stock Comparison
Buy
67
VOX
Vanguard Communication Services ETF
Last Price:
152.07
Seasonality Move:
2.69%
Sell
35
HALO
Halozyme Therapeutics
Last Price:
42.56
Seasonality Move:
17.03%
Buy
67
Vanguard Communication Services ETF (VOX)
is a Buy
Is Vanguard Communication Services ETF a Buy, Sell or Hold?
- The current Vanguard Communication Services ETF [VOX] share price is $152.01. The Score for VOX is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
- VOX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
35
Halozyme Therapeutics (HALO)
is a Sell
Is Halozyme Therapeutics a Buy, Sell or Hold?
- The current Halozyme Therapeutics [HALO] share price is $42.57. The Score for HALO is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
- HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
VOX Stock Price Chart
What is Vanguard Communication Services ETF's stock price today?
-
The Vanguard Communication Services ETF share price today is $152.01
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VOX is experiencing slight buying pressure.
HALO Stock Price Chart
What is Halozyme Therapeutics's stock price today?
-
The Halozyme Therapeutics share price today is $42.57
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.
VOX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0 | Sell |
| Relative Strength Index (14 RSI): | 56.78 | Buy |
| Chaikin Money Flow: | 36284 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
HALO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.04 | Sell |
| Relative Strength Index (14 RSI): | 26.84 | Sell |
| Chaikin Money Flow: | -3822578 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (48.96 - 58.72) | Sell |
| Bollinger Bands (100): | (51.86 - 60.48) | Sell |
VOX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0 | Buy |
| 20-day SMA: | 0 | Buy |
| 50-day SMA: | 0 | Buy |
| 200-day SMA: | 0 | Buy |
| 8-day EMA: | 0 | Buy |
| 20-day EMA: | 0 | Buy |
| 50-day EMA: | 0 | Buy |
| 200-day EMA: | 0 | Buy |
HALO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 55.27 | Sell |
| 20-day SMA: | 54.02 | Sell |
| 50-day SMA: | 55.85 | Sell |
| 200-day SMA: | 48.97 | Sell |
| 8-day EMA: | 52.24 | Sell |
| 20-day EMA: | 54.19 | Sell |
| 50-day EMA: | 55.13 | Sell |
| 200-day EMA: | 50.65 | Sell |
Vanguard Communication Services ETF Earnings Growth & VOX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Halozyme Therapeutics Earnings Growth & HALO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.35 per share, and an increase next year of $0.56 per share.
Vanguard Communication Services ETF Technical Analysis
| Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Halozyme Therapeutics Technical Analysis
| Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||